Iran has the ability to produce 900,000 doses of Sputnik V and 3.5 million Sputnik Light per month.

The results of the clinical trial of the Sputnik Light vaccine in Azerbaijan and Russia have been very successful, Hossein Ali Shahriari, member of the Majlis (Iranian parliament), said.

He said that the injection of the vaccine to the age group of 18 to 50 years has been successful and the results of these studies have caused the speed of vaccination of young people in Russia in critical conditions and now Sputnik Light vaccine is widely injected in 12 countries, which has had beneficial effects in reducing mortality.

“Sputnik vaccine produced in Iran has already gone through all test stages and sent to the Gamalia Institute of Russia to undergo final tests,” he concluded.

Mass vaccination against COVID-19 started on Iranian citizens with the Russian-made Sputnik V vaccine on February 9.

While Iran continues efforts to mass-produce local candidates, over 13 million doses of foreign vaccines have already been imported and others are expected soon.

Iran is also producing vaccines jointly with two countries of Cuba and Australia, which may also be released by September.

According to the Food and Drug Administration, 14 vaccines are being domestically developed in the country which are in different study phases.

The post Iranian-made Sputnik vaccine in final testing phase appeared first on Iran News Daily.

People can express their occupation and illness on this website and be informed about the time of their vaccination, he explained.

He went on to add that by the end of July, mass vaccination will begin and all the people will be informed of when to receive the vaccine, IRNA reported on Saturday.

Iran started mass vaccination against COVID-19 with Sputnik V vaccine on February 9; which is also being co-produced by the two countries and will be released by the end of spring (June 21).

So far, 718,510 doses of coronavirus vaccine, including the first and second doses, have been injected in the country.

Iran is currently producing vaccines jointly with three countries of Cuba, Russia, and Australia, he noted, expressing hope that these vaccines can also be released by September.

Raeisi announced on Thursday that the sixth batch of the “Sputnik V” vaccine, including over 100,000 doses, has been sent to the country.

Of the total vaccines imported so far, we have received about 420,000 doses of Sputnik V, some 650,000 doses from China, and 125,000 from India. We also received 700,000 doses of Astrazeneca vaccine from South Korea, so that a total of 1.895 million doses of vaccine have been provided to the Ministry of Health, he explained.

Homegrown vaccines

COVIRAN BAREKAT, the first coronavirus vaccine made by researchers at the Headquarters for Executing the Order of the Imam which was unveiled on December 29, 2020, started to be mass-produced on March 29.

The second Iranian coronavirus vaccine, Razi Cov Pars, which started the clinical trial on February 27, will be mass-produced in early August.

Fakhra vaccine, the third homegrown vaccine, was unveiled and started the clinical trial on March 16.

Homegrown vaccine “Osvid-19” produced by Osvah Pharmaceutical Company vaccine will also be available in early September.

On January 27, Health Minister Saeed Namaki said Iran will soon be one of the world’s important manufacturers of the COVID-19 vaccine.

The post COVID-19 vaccination system to be launched appeared first on Iran News Daily.

After they are vaccinated, the president continued, “we will move ahead to the second [high-risk] group.”
“All the efforts are aimed at, God willing, importing vaccines and providing people with them … and then the people would be able to move on from this issue toward a more promising future,” he added.
Later in the day, the Iranian Health Ministry said 319 more people had died of the highly infectious disease in the last 24 hours, bringing the total number of recorded deaths from the virus in Iran to 66,327. The ministry also announced 21,312 new cases.

Earlier this month, Rouhani recalled the difficulties of importing sanctions, saying, “Wherever there is a vaccine, we immediately provide money to purchase it.”

“I want to say that this is not a simple matter,” he said. “The administration, the Health Ministry and the Central Bank have taken all the necessary measures … and I stress that nothing comes before the issue of vaccines for us.”

Elsewhere in his Saturday remarks, Rouhani said his administration has made great efforts to develop a homegrown vaccine as soon as possible.
“We are very hopeful that we’d be able to use the domestic vaccine in summer,” the president added.
Last month, the Islamic Republic unveiled a new COVID-19 vaccine developed by the Defense Ministry’s research center. The first phase of the human trial of the vaccine, dubbed Fakhra, was launched during a ceremony in Tehran on March 16.

In addition to Fakhra, Iran has developed three other vaccines, including Coviran Barekat developed by experts at the Headquarters for Executing the Order of Imam Khomeini, Razi COV-Pars vaccine developed by the Razi Vaccine and Serum Research Institute, and Soberana 2 vaccine which is a joint venture between Cuba’s Finlay Vaccine Institute and Iran’s Pasteur Institute.

Iran OK’s phase 3 of Soberana 2’s clinical trial

Also on Saturday, the spokesman for Iran Food and Drug Administration (IFDA) announced that the Iranian Health Ministry has issued a Code of Ethics for phase 3 of the clinical trial research of Soberana 2 vaccine.
“Phase 3 of the clinical trial of this vaccine is the last stage of the studies of this candidate … and if the results are successful and approved, a mass production and consumption license will be issued,” Kianoush Jahanpour told IRIB news.
Jahanpour said phase 3 of the trial began in Cuba a month ago and 48,000 people have so far received the vaccine in that country.
The vaccine “has shown significant safety and efficacy in phases 1 and 2 of its clinical trials and appears to be somehow unique,” he added.

Iran finalizes deal with Russia to import 60 doses of Sputnik V

On Thursday, Iran’s envoy to Moscow said Iran has finalized a contract with Russia to import 60 million doses of the Russian Sputnik V vaccine in the coming months.

Kazem Jalali said the contract was signed between the Iranian Embassy in Moscow and the Russian Direct Investment Fund (RDIF) to buy 60 million doses of the vaccine, which is enough to vaccinate 30 million people.

He also said Iran will receive the vaccines within seven months (May 22-December 21).

Earlier, the head of the RDIF had announced that the production of the Sputnik V will soon be organized in Iran, Serbia and Italy within months.

“The Russian vaccine is already being manufactured in Belarus and Kazakhstan. Production will soon begin in Serbia and Iran. Thus, we sign partnerships with various countries and companies. Apart from that, we expect the vaccine production to be organized at Adienne Pharma & Biotech Italian plant within several months,” Kirill Dmitriev said.

The post Iran to administer 1.4m coronavirus vaccine doses by Friday appeared first on Iran News Daily.

Supported by Iran’s Ministry of Health, the contract was signed between the Iranian Embassy in Moscow and the Russian Direct Investment Fund (RDIF) to buy 60 million doses of vaccine, which is enough to vaccinate 30 million people.

Jalali said that Iran will receive the vaccines through a period of seven months (May 22-December 21), IRNA reported.

Referring to the current contract for two million doses, Jalali stated that some five shipments, amounting to 520,000 doses of vaccine, have so far been sent to Iran, while the Russian side would deliver the rest as soon as possible.

So far, two Iranian companies have signed a contract with the Russian side for the joint production of vaccines in the country, and the third company also has been introduced and is awaiting approval, he concluded.

Last Saturday, Iran began a 10-day lockdown amid the fourth wave of infections.

During the lockdown, shops, parks, restaurants, bakeries, beauty salons, malls, and bookstores are closed and offices restricted to one-third capacity in cities declared as “red zones” with the highest infection rates.

The capital city of Tehran and 250 other cities across the country have been declared red zones.

Homegrown vaccines

COVIRAN BAREKAT, the first coronavirus vaccine made by researchers at the Headquarters for Executing the Order of the Imam which was unveiled on December 29, 2020, started to be mass-produced on March 29.

The second Iranian coronavirus vaccine, Razi Cov Pars, which started the clinical trial on February 27, will be mass-produced in early August.

Fakhra vaccine, the third homegrown vaccine, was unveiled and started the clinical trial on March 16.

On January 27, Health Minister Saeed Namaki said Iran will soon be one of the world’s important manufacturers of the COVID-19 vaccine.

Mass-vaccination

Iran started mass vaccination against COVID-19 with Russian-made Sputnik V vaccine on February 9, with the priority given to medical staff, the elderly, and people with underlying diseases; which is also going to be co-produced by the two countries.

The first shipment of the COVAX vaccine was also delivered to Tehran in early April.

“Currently, about 250,000 people in the country have been vaccinated and about 56,000 others have received the second dose of the vaccine,” Alireza Raeisi, spokesman for the National Headquarters for Coronavirus control said.

The post Iran finalizes deal for 60 million “Sputnik V” vaccines appeared first on Iran News Daily.

The post Venezuela Thanks Russia for Coronavirus Vaccine Supply appeared first on Iran News Daily.